Movement Alert|CSOP 2x Leveraged SK Hynix Rises 7.03% in Regular Trading, SK Hynix Plans August US ADR Listing with SEC Approval Expected This Month

Market Focus
Yesterday

On June 11, CSOP 2x Leveraged SK Hynix (07709) rose 7.03% in regular trading, trading at HK$104.45/share, with trading volume of HK$414 million.

On the news front, reports emerged that SK Hynix plans to list in the US as early as August via American Depositary Receipts, with the SEC likely to approve the application during the week of June 22. The offering could raise up to $14 billion. SK Hynix confirmed it plans to issue ADRs within the year but noted that specific scale and timing remain undetermined.

The rally follows a series of bullish catalysts for the storage chip giant. NVIDIA and SK Hynix announced a multi-year technology partnership on June 8. SK Hynix shares in Korea surged nearly 16% on June 9 amid a global semiconductor rally. The company's market capitalization has surpassed $1 trillion, making it Asia's third company to reach that milestone. SK Hynix also indicated that favorable HBM chip pricing is expected to persist, while NVIDIA's next-generation Vera Rubin platform is projected to tighten overall memory supply from 2027 onward.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10